This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Emerging Biotech Companies Discuss What’s In The Pipeline At NYSSA Conference

Insiders from some of the sector’s most innovative small- and micro-cap biotech companies will discuss their progress with trials and their plans to develop, research, and market important new drugs, diagnostics and delivery technologies at the New York Society of Security Analysts’ 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011.

The agenda also includes an outlook on the industry from Yigal D. Nochomovitz, PhD, senior biotechnology analyst and senior vice president at Rodman & Renshaw, LLC.

A 2011 study indicated that the majority of investors expect that biotech will outperform the overall healthcare sector in 2011 and 2012, with just over one-third forecasting double-digit returns. NYSSA has brought together executives from these emerging biotech companies who will give 35-minute presentations on their company’s prospects to members of the Wall Street community:

  • Cardio3BiosciencesChristian Homsy, CEO
  • DARA BioSciences, Inc. (Nasdaq: DARA)Richard A. Franco, President, CEO and Chairman
  • EpiCept Corporation (Nasdaq: EPTC)Jack Talley, President and CEO
  • Galena Biopharma (Nasdaq: RXII)Mark Schwartz, PhD, EVP and COO
  • NanoViricides, Inc.Eugene Seymour, MD, MPH, CEO
  • OncoSec Medical Inc.Punit Dhillon, President and CEO
  • Provectus Pharmaceuticals, Inc. (OTC: PVCT)Craig Dees, PhD, CEO
  • Senesco Technologies (AMEX: SNT)Leslie J. Browne, President and CEO
  • TONIX Pharmaceuticals (OTCBB: TNXP)Dr. Seth Lederman, President and Chairman

The full-day conference will be held on November 30, 2011 from 8:30 a.m.–4:10 p.m. at NYSSA Conference Center, 1540 Broadway, Suite 1010, New York, NY 10036.

For more information on the conference, please visit: www.nyssa.org/biotech.

There is no charge for press with credentials.

About NYSSA

The New York Society of Security Analysts (NYSSA) is a leading forum for the investment community. NYSSA’s mission is to promote best practices and the highest professional and ethical standards in the industry. With 10,000 members, NYSSA is the largest of the 135 societies worldwide that make up CFA Institute, which has over 105,000 members. For more information about NYSSA, please visit http://www.nyssa.org. Follow NYSSA on Facebook, Twitter and Finance Professionals’ Post.

Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,826.30 -279.47 -1.54%
S&P 500 2,081.18 -23.81 -1.13%
NASDAQ 4,931.8150 -75.9760 -1.52%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs